Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis.
Saved in:
| Title: | Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. |
|---|---|
| Authors: | Kian W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Zemel M; Medical School for International Health, Ben-Gurion University of the Negev., Elobra F; Dermatology Department Soroka Medical Center & Ben-Gurion University., Sharb AA; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Levitas D; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Assabag Y; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Alguayn F; Faculty of Health Sciences, Ben-Gurion University of the Negev., Yakobson A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Rouvinov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Fuchs L; Medical Intensive care Unit, Soroka University Medical Center, Beer-Sheva, Israel. |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2022 Jan 01; Vol. 33 (1), pp. e738-e740. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34321417 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kian+W%22">Kian W</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Zemel+M%22">Zemel M</searchLink>; Medical School for International Health, Ben-Gurion University of the Negev.<br /><searchLink fieldCode="AU" term="%22Elobra+F%22">Elobra F</searchLink>; Dermatology Department Soroka Medical Center & Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Sharb+AA%22">Sharb AA</searchLink>; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Levitas+D%22">Levitas D</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Assabag+Y%22">Assabag Y</searchLink>; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Alguayn+F%22">Alguayn F</searchLink>; Faculty of Health Sciences, Ben-Gurion University of the Negev.<br /><searchLink fieldCode="AU" term="%22Yakobson+A%22">Yakobson A</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Rouvinov+K%22">Rouvinov K</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University.<br /><searchLink fieldCode="AU" term="%22Fuchs+L%22">Fuchs L</searchLink>; Medical Intensive care Unit, Soroka University Medical Center, Beer-Sheva, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229100823%22">Anti-cancer drugs</searchLink> [Anticancer Drugs] 2022 Jan 01; Vol. 33 (1), pp. e738-e740. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9100823 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5741 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209594973%22">09594973 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34321417 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/CAD.0000000000001162 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e738 Titles: – TitleFull: Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kian W – PersonEntity: Name: NameFull: Zemel M – PersonEntity: Name: NameFull: Elobra F – PersonEntity: Name: NameFull: Sharb AA – PersonEntity: Name: NameFull: Levitas D – PersonEntity: Name: NameFull: Assabag Y – PersonEntity: Name: NameFull: Alguayn F – PersonEntity: Name: NameFull: Yakobson A – PersonEntity: Name: NameFull: Rouvinov K – PersonEntity: Name: NameFull: Fuchs L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Jan 01 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1473-5741 Numbering: – Type: volume Value: 33 – Type: issue Value: 1 Titles: – TitleFull: Anti-cancer drugs Type: main |
| ResultId | 1 |